Approval · Notice of Compliance 6372 · 2005
APO-METHYLPHENIDATE SR: Notice of Compliance 6372
Issued March 31, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6372
- Date
- March 31, 2005
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Central nervous system stimulant
- Canadian reference product
- RITALIN SR (Novartis Pharmaceuticals Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-METHYLPHENIDATE SR | 02266687 | Marketed |
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 20 MG per TAB